The pandemic has wrought enormous changes in our world, and perhaps no industry has been greater affected than life sciences in general and pharmaceuticals in particular. COVID-19 has forced pharma companies to rethink how they do business to become more efficient and stay on top in a highly competitive environment. These are challenging times, no doubt, but it’s an era that also offers significant opportunity in a changing landscape.